Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors
US11834467B2 · kind B2 · utility
0Cited by
5References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2021 |
| Grant date | Dec 5, 2023 |
| Priority date | — |
| Expiry date | Oct 14, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, a composition comprising the compound, methods of using the compound for the treatment of various disorders associated with HPK1, and methods of preparing these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.